Target intelligence / Profile preview

Thiamine pyrophosphate-dependent metabolic enzymes (TPP-dependent enzymes)

Target
TPP-dependent enzymes
Molecular classification
Enzyme, Oxidoreductase, Lyase, Transferase
01

Overview

Thiamine pyrophosphate (TPP)-dependent metabolic enzymes are a diverse group of enzymes that utilize thiamine pyrophosphate (the active form of Vitamin B1) as an essential cofactor to catalyze the cleavage of carbon-carbon bonds adjacent to a carbonyl group (PubMed: 24533648). Key members include the pyruvate dehydrogenase complex (PDC), alpha-ketoglutarate dehydrogenase (KGDH), branched-chain alpha-keto acid dehydrogenase (BCKDH), and transketolase (TKT). These enzymes play critical roles in central energy metabolism, the citric acid cycle, and the pentose phosphate pathway, facilitating the conversion of nutrients into cellular energy and biosynthetic precursors (StatPearls: NBK537204). Dysregulation or deficiency of these enzymes is linked to metabolic disorders like maple syrup urine disease and neurological conditions such as Wernicke-Korsakoff syndrome (NIH: NBK1144). In oncology, certain TPP-dependent enzymes like transketolase-like 1 (TKTL1) are often upregulated in tumors to support the Warburg effect, making them potential targets for cancer therapy (PubMed: 28811344). Additionally, because many pathogens rely on unique TPP-dependent pathways, these enzymes are explored as targets for antimicrobial and antiparasitic drugs.

Other names
Thiamin diphosphate-dependent enzymesThDP-dependent enzymesTPP-dependent enzymesThiamine-dependent enzymes
02

Mechanism of action

These enzymes are targeted primarily through cofactor supplementation to restore metabolic function or through competitive inhibition of the TPP-binding site to disrupt metabolic pathways in cancer cells or pathogens.

03

Biological functions

Carbohydrate metabolismAmino acid metabolismEnergy productionPentose phosphate pathwayCitric acid cycle
04

Disease associations

Thiamine deficiencyWernicke-Korsakoff syndromeMaple syrup urine diseasePyruvate dehydrogenase deficiencyCancerInfectionDiabetes mellitus
05

Safety considerations

Risk of metabolic acidosisPotential for Wernicke-like encephalopathy if inhibitedHypersensitivity to thiamine analogs
06

Interacting drugs

Thiamine

6 more in the full profile.

07

Biomarkers

Erythrocyte transketolase activity (ETKA)Thiamine pyrophosphate effect (TPPE)Blood thiamine diphosphate concentration

Beyond the preview

Go deeper on Thiamine pyrophosphate-dependent metabolic enzymes (TPP-dependent enzymes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiamine pyrophosphate-dependent metabolic enzymes (TPP-dependent enzymes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call